Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfb7a09a2dd4df62959191f4814dc104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c2a50ebe4f84653dedd230a0f4a3103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6121c499004f972d53c771bff7f2b53 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-838 |
filingDate |
2009-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0168537d25d95fee9770df5072cf133a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4f412bc9809a9330726786afcc8c523 |
publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009099136-A1 |
titleOfInvention |
Calcium phosphate composition and process for production thereof |
abstract |
A calcium phosphate composition comprising calcium phosphate particles (A) and a sulfonic acid salt (B), characterized in that the content of the sulfonic acid salt (B) is 0.5 to 20 parts by weight per 100 parts by weight of the particles (A). When used in a clinical site or the like, the composition exhibits a hardening time (a time necessary for the composition to harden after the addition of a liquid agent) within an appropriate range, and can form a hardened mass which has high mechanical strengths and attain excellent peripheral sealing. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010113800-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9415068-B2 |
priorityDate |
2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |